Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (121-130 of 687) with videos related to

Pageof 69
Sort By:
European Journal of Heart Failure|September 6, 2018
Revisiting hyperkalaemia guidelines: rebuttalJaved Butler, Shilpa Vijayakumar, Bertram Pitt
Kidney360|June 18, 2025
Potassium Dysregulation in Patients with CKD: Time to Focus on Low Potassium Intake and HypokalemiaChristopher Wilcox, Anand Vaidya, Bertram Pitt
Current Cardiology Reports|June 9, 2004
Eplerenone: will it have a role in the treatment of acute coronary syndromes?David J Meier, Bertram Pitt, Sanjay Rajagopalan
Journal of the American Heart Association|March 10, 2026
Diuretic Strategies in Acute Heart Failure: Marker of Risk or Modifiable Target?Linda Ye, Bertram Pitt, Andrew P Ambrosy
Circulation|July 10, 2002
Cyclooxygenase-2 inhibition and cardiovascular eventsBertram Pitt, Carl Pepine, James T Willerson
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 7, 2019
Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developmentsFaiez Zannad, João Pedro Ferreira, Bertram Pitt
Cell Metabolism|November 3, 2021
EMPEROR-Preserved: A promise fulfilledDeepak L Bhatt, Subodh Verma, Bertram Pitt
European Heart Journal|August 18, 2022
Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?Bertram Pitt, Deepak L Bhatt, Marco Metra
European Journal of Heart Failure|June 15, 2022
Left ventricular ejection fraction as the primary heart failure phenotyping parameterLars H Lund, Bertram Pitt, Marco Metra
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 11, 2003
Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular diseaseBertram Pitt, Charles T Stier, Sanjay Rajagopalan
Pageof 69

Showing results (121-130 of 687) with videos related to

Sort By:
Pageof 69
European Journal of Heart Failure|September 6, 2018
Revisiting hyperkalaemia guidelines: rebuttalJaved Butler, Shilpa Vijayakumar, Bertram Pitt
Kidney360|June 18, 2025
Potassium Dysregulation in Patients with CKD: Time to Focus on Low Potassium Intake and HypokalemiaChristopher Wilcox, Anand Vaidya, Bertram Pitt
Current Cardiology Reports|June 9, 2004
Eplerenone: will it have a role in the treatment of acute coronary syndromes?David J Meier, Bertram Pitt, Sanjay Rajagopalan
Journal of the American Heart Association|March 10, 2026
Diuretic Strategies in Acute Heart Failure: Marker of Risk or Modifiable Target?Linda Ye, Bertram Pitt, Andrew P Ambrosy
Circulation|July 10, 2002
Cyclooxygenase-2 inhibition and cardiovascular eventsBertram Pitt, Carl Pepine, James T Willerson
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 7, 2019
Potassium binders for the prevention of hyperkalaemia in heart failure patients: implementation issues and future developmentsFaiez Zannad, João Pedro Ferreira, Bertram Pitt
Cell Metabolism|November 3, 2021
EMPEROR-Preserved: A promise fulfilledDeepak L Bhatt, Subodh Verma, Bertram Pitt
European Heart Journal|August 18, 2022
Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?Bertram Pitt, Deepak L Bhatt, Marco Metra
European Journal of Heart Failure|June 15, 2022
Left ventricular ejection fraction as the primary heart failure phenotyping parameterLars H Lund, Bertram Pitt, Marco Metra
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 11, 2003
Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular diseaseBertram Pitt, Charles T Stier, Sanjay Rajagopalan
Pageof 69